Google
×
Hematopoietic stem cell transplantation (HSCT) is a lifesaving expensive medical procedure. Hence, more transplants are performed in more affluent countries.
Nov 19, 2015 · Study design. This retrospective observational analysis was based on a previously published cohort. It consists of patients transplanted between ...
Nov 25, 2015 · The impact of economic factors on patient outcome is less defined. We analyzed retrospectively a defined cohort of 102,549 patients treated with ...
Abstract: Hematopoietic stem cell transplantation (HSCT) is a lifesaving expensive medical procedure. Hence, more transplants are performed in more affluent ...
Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study ... Authors: Alois Gratwohl; Anna Sureda; Helen Baldomero ...
Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study · journal article · research article · Published by Elsevier in ...
The impact of economic factors on patient outcome is less defined. We analyzed retrospectively a defined cohort of 102,549 patients treated with an allogeneic ( ...
Dec 20, 2017 · Economics and outcome after hematopoietic stem cell transplantation: a retrospective cohort study ... hematopoietic stem cell transplantation ...
via crossref, Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: a 5-year analysis within the Swiss Transplant ...
People also ask
Aug 27, 2019 · Economics and outcome after hematopoietic stemcell transplantation: a retrospective cohort study. EBioMedicine. 2015;2:2101–9. Article ...